Results 191 to 200 of about 329,705 (242)
Steroidomic Changes in the Cerebrospinal Fluid of Women with Multiple Sclerosis. [PDF]
Kancheva R +9 more
europepmc +1 more source
ABSTRACT Objectives To evaluate the impact of the extent of resection and adjuvant radiotherapy (RT) on treatment outcomes in patients with early‐stage olfactory neuroblastoma (ONB) without definite dural invasion. Methods A retrospective review of ONB cases from two centers within a single institution between 1992 and 2023 was performed ...
Tae‐Bin Won +8 more
wiley +1 more source
Cerebral Small Vessel Disease in Older Adults With Olfactory Dysfunction
ABSTRACT Background Poor vascular health has been associated with age‐related declines in sensory functions, including olfaction. The current study was designed to test the hypothesis that cerebral small vessel disease underlies poor olfactory function due to structural declines in brain regions that support olfaction.
Mark A. Eckert +3 more
wiley +1 more source
Social anxiety disorder and antibodies against glial cells in the cerebrospinal fluid. [PDF]
Weiser J +12 more
europepmc +1 more source
Complications in Endoscopic Sinus Surgery: A TriNetX Network Analysis
Abstract Background The potential complications of endoscopic sinus surgery (ESS) remain a critical surgical consideration. This study aims to examine complication rates and identify trends in ESS‐related complications. Methods The TriNetX network was queried for patients undergoing ESS between 2005 and 2024.
Jakob L. Fischer +8 more
wiley +1 more source
Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review. [PDF]
Romozzi M +11 more
europepmc +1 more source
Amantadine (AMA) regulates neurocyte apoptosis and inhibits neurocyte inflammation to prevent maternal immune activation (MIA) from affecting offspring behavior. Abstract Background Maternal viral infection during pregnancy can lead to maternal immune activation (MIA), increasing the risk of neurodevelopmental disorders in offspring.
Jianfei Wu +8 more
wiley +1 more source
Evaluation of the diagnostic efficacy of core biomarkers in cerebrospinal fluid for Alzheimer's disease: a systematic review and meta-analysis. [PDF]
Deng B +5 more
europepmc +1 more source
Objective Tofersen is the first effective and approved therapy for superoxide dismutase 1 (SOD1)‐associated amyotrophic lateral sclerosis (ALS [SOD1‐ALS]). Following treatment with tofersen, neurofilament levels in patients' cerebrospinal fluid (CSF) and serum seem to respond earlier than clinical parameters.
Christina Steffke +36 more
wiley +1 more source
Fluorometric Nanoscale Analysis of Bilirubin and Biliverdin in Human Cerebrospinal Fluid. [PDF]
Sist P +4 more
europepmc +1 more source

